IFF has hired an adviser to help it weigh a potential sale of its pharma solutions unit, Bloomberg’s Kiel Porter, Crystal Tse, and Dinesh Nair report, citing people with knowledge of the matter. The business could bring in over $3.5B in a sale, the authors note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IFF: